权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes

人多能干细胞来源的心肌细胞的成熟

基本信息

批准号：
10091506
负责人：
Chunhui Xu
金额：
$ 39万
依托单位：
EMORY UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-02-01 至 2023-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10091506
关键词：
3-Dimensional Address Adverse event Agonist Arrhythmia Biogenesis Birth Cardiac Cardiac Myocytes Cardiomyopathies Cardiotoxicity Cell Cycle Cells Chemicals Clinical Research Consumption Cues Data Developmental Biology Disease model Down-Regulation Drug usage Fatty Acids Gene Expression Generations Glucose Glycolysis Goals Heart Human Human Development In Vitro Levocarnitine Lipids Mediating Metabolic Metabolism Mitochondria Molecular Molecular Structure Mutation Neonatal Newborn Infant Oxygen PPAR alpha Pathway interactions Pharmacology Physiological Play Production Publications Regenerative Medicine Regulation Role Signal Pathway Signal Transduction Source Structure Testing Thyronines Tissue Engineering Transplantation cardiac tissue engineering cardiogenesis drug discovery experience fatty acid oxidation fetal heart metabolism human disease human model human pluripotent stem cell improved in vivo induced pluripotent stem cell inhibitor/antagonist insight metabolomics novel postnatal preclinical study response sensor stem cells transcriptomics

项目摘要

MATURATION OF HUMAN PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES PROJECT SUMMARY Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) provide a novel and physiologically relevant source of cells that have the potential to be used for in vitro cardiotoxicity testing and disease modeling as well as for the study of in vivo heart development and regenerative medicine. However, compared with primary human CMs, hPSC-CMs are structurally and functionally less mature, which limits their ability to accurately predict cardiotoxicity and model human development and diseases, and may result in adverse events such as arrhythmias upon transplantation. Therefore, improving hPSC-CM maturation is paramount in order to improve applications of these cells. We and other groups have previously demonstrated that efficient CM differentiation from hPSCs can be achieved via mimicking molecular signaling of cardiac induction during in vivo cardiogenesis. In our recent publications, we have also shown that microscale tissue engineering enables reliable generation of 3D cardiac spheres that contain highly enriched hPSC-CMs with enhanced sarcomeric structural maturation. We hypothesize that a multipronged, synergistic approach combining tissue engineering with modulation of multiple molecular signaling pathways can efficiently improve hPSC-CM maturation within short culture durations. With this hypothesis, we aim to enable metabolic and functional maturation of hPSC-CMs by providing the cells with (1) appropriate chemical signals to modulate metabolic maturation and (2) suitable environmental cues to mimic the transition from fetal CMs to postnatal CMs. We expect that this study will lead to the establishment of hPSC-CMs with cardiophysiology closer to human hearts, which will facilitate their applications in preclinical and clinical studies, and provide novel insights into molecular regulation of CM maturation.

人多能干细胞源性心肌细胞的成熟项目摘要人多能干细胞衍生的心肌细胞（hPSC-CM）提供了一种新的和生理相关的心肌细胞。具有用于体外心脏毒性测试和疾病建模的潜力的细胞来源至于体内心脏发育和再生医学的研究。与小学相比，人CM、hPSC-CM在结构上和功能上较不成熟，这限制了它们准确地表达预测心脏毒性，模拟人类发育和疾病，并可能导致不良事件，如移植后心律失常。因此，改善hPSC-CM成熟是至关重要的，以便改善这些细胞的应用。我们和其他小组先前已经证明，有效的CM分化可以通过模拟体内心脏发生期间心脏诱导的分子信号传导来实现。在我们最近的出版物中，我们还表明，微尺度组织工程能够可靠地产生的3D心脏球体，其含有具有增强的肌节结构成熟的高度富集的hPSC-CM。我们假设，一种多管齐下的，协同的方法，结合组织工程与调节，多种分子信号通路可有效促进hPSC-CM在短培养时间内成熟持续时间。根据这一假设，我们的目标是通过提供以下途径使hPSC-CM能够代谢和功能成熟：细胞具有（1）调节代谢成熟的适当化学信号和（2）合适的环境条件，提示模仿从胎儿CM到出生后CM的转变。我们预计，这项研究将导致建立更接近人体心脏的hPSC-CM，为hPSC-CM的临床应用奠定基础在临床前和临床研究，并提供新的见解CM成熟的分子调控。

项目成果

期刊论文数量（10）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Targeted Elimination of Tumorigenic Human Pluripotent Stem Cells Using Suicide-Inducing Virus-like Particles.

DOI：
10.1021/acschembio.8b00490
发表时间：
2018-08-17
期刊：
ACS chemical biology
影响因子：
4
作者：
Rampoldi A;Crooke SN;Preininger MK;Jha R;Maxwell J;Ding L;Spearman P;Finn MG;Xu C
通讯作者：
Xu C

Space microgravity increases expression of genes associated with proliferation and differentiation in human cardiac spheres.

DOI：
10.1038/s41526-023-00336-6
发表时间：
2023-12-09
期刊：
NPJ MICROGRAVITY
影响因子：
5.1
作者：
Hwang, Hyun;Rampoldi, Antonio;Forghani, Parvin;Li, Dong;Fite, Jordan;Boland, Gene;Maher, Kevin;Xu, Chunhui
通讯作者：
Xu, Chunhui

Simulated microgravity improves maturation of cardiomyocytes derived from human induced pluripotent stem cells.

DOI：
10.1038/s41598-024-52453-1
发表时间：
2024-01-26
期刊：
Scientific reports
影响因子：
4.6
作者：
通讯作者：

Space microgravity improves proliferation of human iPSC-derived cardiomyocytes.

太空微重力可改善人类 iPSC 来源的心肌细胞的增殖。

DOI：
10.1016/j.stemcr.2022.08.007
发表时间：
2022-10-11
期刊：
STEM CELL REPORTS
影响因子：
5.9
作者：
Rampoldi, Antonio;Forghani, Parvin;Li, Dong;Hwang, Hyun;Armand, Lawrence Christian;Fite, Jordan;Boland, Gene;Maxwell, Joshua;Maher, Kevin;Xu, Chunhui
通讯作者：
Xu, Chunhui

A long non-coding RNA GATA6-AS1 adjacent to GATA6 is required for cardiomyocyte differentiation from human pluripotent stem cells.

DOI：
10.1096/fj.202000206r
发表时间：
2020-11
期刊：
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
影响因子：
0
作者：
Jha R;Li D;Wu Q;Ferguson KE;Forghani P;Gibson GC;Xu C
通讯作者：
Xu C